30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Vultaggio Vincent

Track

Insider profile

Performance

Overall performance
1.6
Performance over holding periods
1.6
30 days 90 days 120 days
Average return -4% 8.2% 15.1%
Success rate 7% 68% 82%
Transactions
4 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Vultaggio Vincent's trades of Zentalis Pharmaceuticals Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-02-10 2026-02-10
PlS Planned sale
30,346 -20.0%
125.13
US$1,141,369 		30,346 -20.0% 125.13 US$1,141,369
2026-02-10 2026-02-09
S Sale
65,419 +18.6%
120.38
US$593,249 		65,419 +18.6% 120.38 US$593,249
2026-02-10 2026-02-06
S Sale
27,699 -23.7%
403.99
US$1,915,349 		27,699 -23.7% 403.99 US$1,915,349
2026-02-04 2026-02-03
PlS Planned sale
556 -0.3%
2.52
US$1,398 		556 -0.3% 2.52 US$1,398
2026-02-04 2026-02-03
PlS Planned sale
556 -0.3%
2.52
US$1,398 		556 -0.3% 2.52 US$1,398
2026-02-04 2026-02-02
S Sale
2,540 -1.3%
2.55
US$6,477 		2,540 -1.3% 2.55 US$6,477
2025-02-05 2025-02-03
S Sale
2,615 -1.4%
1.71
US$4,476 		2,615 -1.4% 1.71 US$4,476
2024-10-04 2024-10-04
PlS Planned sale
1,603 -4.5%
3.18
US$5,098 		1,603 -4.5% 3.18 US$5,098